Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $84.9 million.

  • Sutro Biopharma's Shares Outstanding (Weighted Average) rose 344.47% to $84.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.9 million, marking a year-over-year increase of 344.47%. This contributed to the annual value of $76.8 million for FY2024, which is 2770.06% up from last year.
  • Sutro Biopharma's Shares Outstanding (Weighted Average) amounted to $84.9 million in Q3 2025, which was up 344.47% from $84.6 million recorded in Q2 2025.
  • In the past 5 years, Sutro Biopharma's Shares Outstanding (Weighted Average) registered a high of $84.9 million during Q3 2025, and its lowest value of $45.9 million during Q1 2021.
  • In the last 5 years, Sutro Biopharma's Shares Outstanding (Weighted Average) had a median value of $60.2 million in 2023 and averaged $61.8 million.
  • In the last 5 years, Sutro Biopharma's Shares Outstanding (Weighted Average) soared by 9789.49% in 2021 and then soared by 128.96% in 2022.
  • Over the past 5 years, Sutro Biopharma's Shares Outstanding (Weighted Average) (Quarter) stood at $46.1 million in 2021, then grew by 10.02% to $50.7 million in 2022, then increased by 18.57% to $60.2 million in 2023, then rose by 27.7% to $76.8 million in 2024, then grew by 10.47% to $84.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $84.9 million in Q3 2025, compared to $84.6 million in Q2 2025 and $83.1 million in Q1 2025.